Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daria Zdżalik-Bielecka
Observed names:
D. Zdzalik,
Daria Zdzalik,
Daria Zdżalik
Institution:
University of Warsaw
Observed institutions:
University of Oslo,
Queen's University,
Celon Pharma (Poland),
International Institute of Molecular and Cell Biology,
Medical University of Lodz,
Mossakowski Medical Research Institute, Polish Academy of Sciences,
University of Warsaw
show all 7
ORCID:
0000-0003-3096-8293
Observed ORCID:
0000-0003-3096-8293
OpenAlex ID:
A5055084960
Works
30
Awards
1
Damage of DNA and proteins by major lipid peroxidation products in genome stability
2012
·
Alicja Winczura
, Daria Zdżalik
, et al.
·
Free Radical Research
·
131
The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion
2021
·
Daria Zdżalik-Bielecka
, Agata Poświata
, et al.
·
Proceedings of the National Academy of Sciences
·
111
PDF
Lipid peroxidation in face of DNA damage, DNA repair and other cellular processes
2016
·
Barbara Tudek
, Daria Zdżalik-Bielecka
, et al.
·
Free Radical Biology and Medicine
·
94
ESCRT proteins restrict constitutive NF-κB signaling by trafficking cytokine receptors
2016
·
Agnieszka Mamińska
, Anna Bartosik
, et al.
·
Science Signaling
·
83
Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells
2014
·
Paulina Grygielewicz
, Barbara Dymek
, et al.
·
Gastric Cancer
·
70
PDF
Multiple routes of endocytic internalization of PDGFRβ contribute to PDGF-induced STAT3 signaling
2017
·
Kamil Jastrzębski
, Daria Zdżalik-Bielecka
, et al.
·
Journal of Cell Science
·
59
Discovery and optimization of novel pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR (1–3)
2020
·
Abdellah Yamani
, Daria Zdżalik-Bielecka
, et al.
·
European Journal of Medicinal Chemistry
·
49
Differential repair of etheno-DNA adducts by bacterial and human AlkB proteins
2015
·
Daria Zdżalik
, Anna Domańska
, et al.
·
DNA repair
·
44
Protozoan ALKBH8 Oxygenases Display both DNA Repair and tRNA Modification Activities
2014
·
Daria Zdżalik
, Cathrine B. Vågbø
, et al.
·
PLoS ONE
·
41
PDF
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
2014
·
Daria Zdzalik
, Barbara Dymek
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
41
PDF
Bemcentinib and Gilteritinib Inhibit Cell Growth and Impair the Endo-Lysosomal and Autophagy Systems in an AXL-Independent Manner
2021
·
Daria Zdżalik-Bielecka
, Kamila Kozik
, et al.
·
Molecular Cancer Research
·
21
PDF
Endocytic trafficking of GAS6–AXL complexes is associated with sustained AKT activation
2022
·
Agata Poświata
, Kamila Kozik
, et al.
·
Cellular and Molecular Life Sciences
·
17
Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II—Benzimidazole Derivatives
2022
·
Mariola Stypik
, Stanisław Michałek
, et al.
·
Pharmaceuticals
·
11
PDF
Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer
2024
·
Delfina Popiel
, Aleksandra Stańczak
, et al.
·
Frontiers in Oncology
·
7
Discovery of TRAF-2 and NCK-interacting kinase (TNIK) inhibitors by ligand-based virtual screening methods
2015
·
Anna Bujak
, Filip Stefaniak
, et al.
·
MedChemComm
·
7
Design, Synthesis, and Development of pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part I—Indole Derivatives
2022
·
Mariola Stypik
, Marcin Zagozda
, et al.
·
Pharmaceuticals
·
4
PDF
Na skrzyżowaniu immunologii i onkologii: receptory TAM w regulacji odpowiedzi immunologicznej i procesów związanych z nowotworzeniem
2025
·
Weronika Tokarska-Domżałowicz
, Daria Zdżalik-Bielecka
·
Postępy Biochemii
·
1
PDF
DNA damage, repair and the improvement of cancer therapy – A tribute to the life and research of Barbara Tudek
2020
·
Agnieszka Tudek
, Jolanta Czerwińska
, et al.
·
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
·
1
Supplementary Data from Bemcentinib and Gilteritinib Inhibit Cell Growth and Impair the Endo-Lysosomal and Autophagy Systems in an AXL-Independent Manner
2023
·
Daria Zdżalik-Bielecka
, Kamila Kozik
, et al.
Supplementary Data from Bemcentinib and Gilteritinib Inhibit Cell Growth and Impair the Endo-Lysosomal and Autophagy Systems in an AXL-Independent Manner
2023
·
Daria Zdżalik-Bielecka
, Kamila Kozik
, et al.
PDF
Data from Bemcentinib and Gilteritinib Inhibit Cell Growth and Impair the Endo-Lysosomal and Autophagy Systems in an AXL-Independent Manner
2023
·
Daria Zdżalik-Bielecka
, Kamila Kozik
, et al.
Data from Bemcentinib and Gilteritinib Inhibit Cell Growth and Impair the Endo-Lysosomal and Autophagy Systems in an AXL-Independent Manner
2023
·
Daria Zdżalik-Bielecka
, Kamila Kozik
, et al.
Therapeutic potential of CPL-407-105 – Novel potent JAK/STAT pathway inhibitor for the treatment of asthma
2014
·
Pawel Gunerka
, Barbara Dymek
, et al.
·
European Respiratory Journal
Preclinical characterization of CPL-302-201, a novel, highly potent and selective PI3Kδ inhibitor for the treatment of inflammatory disorders
2014
·
Pawel Gunerka
, Barbara Dymek
, et al.
·
European Respiratory Journal
P1‐024: Characterization of a Novel Group of Phosphodiesterase 9a Inhibitors as Putative Therapeutics for Cognitive Dysfunction
2014
·
Mikolaj Matloka
, Sylwia Janowska
, et al.
·
Alzheimer s & Dementia
Show more works
View as search
Works count:
30
Citation count:
792
H-index:
12
I10-index:
13
Year
Topic
Type
